{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T20:22:34Z","timestamp":1789417354055,"version":"build-2803163510"},"reference-count":20,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Joint Bone Spine"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1016\/j.jbspin.2016.10.013","type":"journal-article","created":{"date-parts":[[2016,11,25]],"date-time":"2016-11-25T22:01:15Z","timestamp":1480111275000},"page":"709-713","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["A pilot study of CXCL8 levels in crystal proven gout patients during allopurinol treatment and their association with cardiovascular disease"],"prefix":"10.1016","volume":"84","author":[{"given":"Laura","family":"Kienhorst","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hein","family":"Janssens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy","family":"Radstake","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piet","family":"van Riel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes","family":"Jacobs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elly","family":"van Koolwijk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellen","family":"van Lochem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthijs","family":"Janssen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jbspin.2016.10.013_bib0105","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1161\/CIRCULATIONAHA.107.703389","article-title":"Independent impact of gout on mortality and risk for coronary heart disease","volume":"116","author":"Choi","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.jbspin.2016.10.013_bib0110","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1136\/ard.2006.055269","article-title":"EULAR evidence based recommendations for gout. Part II: management. Report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT)","volume":"65","author":"Zhang","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2016.10.013_bib0115","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1002\/art.1780340716","article-title":"Monocyte-derived neutrophil chemotactic factor\/interleukin-8 is a potential mediator of crystal-induced inflammation","volume":"34","author":"Terkeltaub","year":"1991","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jbspin.2016.10.013_bib0120","doi-asserted-by":"crossref","first-page":"3303","DOI":"10.1002\/art.39318","article-title":"Gout is a chronic inflammatory disease in which high levels of interleukin-8 (CXCL8), myeloid-related protein 8\/myeloid-related protein 14 complex, and an altered proteome are associated with diabetes mellitus and cardiovascular disease","volume":"67","author":"Kienhorst","year":"2015","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.jbspin.2016.10.013_bib0125","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1161\/CIRCHEARTFAILURE.109.868604","article-title":"Uric acid-lowering treatment with benzbromarone in patients with heart failure: a double-blind placebo-controlled crossover preliminary study","volume":"3","author":"Ogino","year":"2010","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.jbspin.2016.10.013_bib0130","doi-asserted-by":"crossref","first-page":"2508","DOI":"10.1161\/CIRCULATIONAHA.106.651117","article-title":"High-dose allopurinol improves endothelial function by profoundly reducing vascular oxidative stress and not by lowering uric acid","volume":"114","author":"George","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.jbspin.2016.10.013_bib0135","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1136\/annrheumdis-2012-202972","article-title":"Impact of allopurinol on risk of myocardial infarction","volume":"74","author":"Grimaldi-Bensouda","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2016.10.013_bib0140","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1136\/heart.87.3.229","article-title":"Effect of allopurinol on mortality and hospitalisations in chronic heart failure: a retrospective cohort study","volume":"87","author":"Struthers","year":"2002","journal-title":"Heart"},{"key":"10.1016\/j.jbspin.2016.10.013_bib0145","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1136\/ard.2009.113696","article-title":"EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis","volume":"69","author":"Peters","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2016.10.013_bib0150","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1007\/s00296-011-1900-4","article-title":"Subclinical atherosclerosis in gouty arthritis patients: a comparative study","volume":"32","author":"Cukurova","year":"2012","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.jbspin.2016.10.013_bib0155","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1161\/01.ATV.16.8.1007","article-title":"Interleukin-8 production by macrophages from atheromatous plaques","volume":"16","author":"Apostolopoulos","year":"1996","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jbspin.2016.10.013_bib0160","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1515\/CCLM.2003.161","article-title":"Stimulatory effect of homocysteine on interleukin-8 expression in human endothelial cells","volume":"41","author":"Geisel","year":"2003","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.jbspin.2016.10.013_bib0165","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1161\/01.ATV.17.2.317","article-title":"Macrophages isolated from human atherosclerotic plaques produce IL-8, and oxysterols may have a regulatory function for IL-8 production","volume":"17","author":"Liu","year":"1997","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jbspin.2016.10.013_bib0170","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S0021-9150(96)05968-0","article-title":"Interleukin-6 and interleukin-8 protein and gene expression in human arterial atherosclerotic wall","volume":"127","author":"Rus","year":"1996","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jbspin.2016.10.013_bib0175","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.cardiores.2004.01.002","article-title":"Native LDL induces interleukin-8 expression via H2O2, p38 Kinase, and activator protein-1 in human aortic smooth muscle cells","volume":"62","author":"Ryoo","year":"2004","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.jbspin.2016.10.013_bib0180","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.ijcard.2007.02.012","article-title":"Interleukin-8 as an independent predictor of long-term clinical outcome in patients with coronary artery disease","volume":"124","author":"Inoue","year":"2008","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jbspin.2016.10.013_bib0185","doi-asserted-by":"crossref","first-page":"c51","DOI":"10.1159\/000088923","article-title":"Interleukin-8 is a powerful prognostic predictor of all-cause and cardiovascular mortality in dialytic patients","volume":"102","author":"Panichi","year":"2006","journal-title":"Nephron Clin Pract"},{"key":"10.1016\/j.jbspin.2016.10.013_bib0190","doi-asserted-by":"crossref","first-page":"7A","DOI":"10.1016\/S0002-9149(02)03144-2","article-title":"Role of oxidative stress in atherosclerosis","volume":"91","author":"Harrison","year":"2003","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jbspin.2016.10.013_bib0195","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1136\/heartjnl-2012-302249","article-title":"Allopurinol: novel indications in cardiovascular disease","volume":"98","author":"Struthers","year":"2012","journal-title":"Heart"},{"key":"10.1016\/j.jbspin.2016.10.013_bib0200","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1111\/j.1755-5922.2011.00277.x","article-title":"Xanthine oxidase inhibition for the treatment of cardiovascular disease: a systematic review and meta-analysis","volume":"30","author":"Higgins","year":"2012","journal-title":"Cardiovasc Ther"}],"container-title":["Joint Bone Spine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1297319X16302135?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1297319X16302135?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,6]],"date-time":"2018-09-06T10:55:25Z","timestamp":1536231325000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1297319X16302135"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":20,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["S1297319X16302135"],"URL":"https:\/\/doi.org\/10.1016\/j.jbspin.2016.10.013","relation":{},"ISSN":["1297-319X"],"issn-type":[{"value":"1297-319X","type":"print"}],"subject":[],"published":{"date-parts":[[2017,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A pilot study of CXCL8 levels in crystal proven gout patients during allopurinol treatment and their association with cardiovascular disease","name":"articletitle","label":"Article Title"},{"value":"Joint Bone Spine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jbspin.2016.10.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Soci\u00e9t\u00e9 fran\u00e7aise de rhumatologie. Published by Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}